ESSA Pharma (EPI) opened at C$0.30 on Thursday. The company has a market capitalization of $8.72 and a PE ratio of -1.43. ESSA Pharma has a twelve month low of C$0.22 and a twelve month high of C$4.60.
ESSA Pharma (CVE:EPI) last announced its earnings results on Monday, December 11th. The company reported C($0.11) EPS for the quarter.
About ESSA Pharma
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.